Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

bioRxiv logoLink to bioRxiv
[Preprint]. 2023 Mar 22:2023.03.20.530986. [Version 1] doi: 10.1101/2023.03.20.530986

Structural basis for functional properties of cytochrome c oxidase

Izumi Ishigami 1, Raymond G Sierra 2, Zhen Su 2,3, Ariana Peck 2, Cong Wang 2, Frederic Poitevin 2, Stella Lisova 2, Brandon Hayes 2, Frank R Moss III 2,, Sébastien Boutet 2, Robert E Sublett 2, Chun Hong Yoon 2, Syun-Ru Yeh 1,*, Denis L Rousseau 1,*
PMCID: PMC10055264  PMID: 36993562

Abstract

Cytochrome c oxidase (CcO) is an essential enzyme in mitochondrial and bacterial respiration. It catalyzes the four-electron reduction of molecular oxygen to water and harnesses the chemical energy to translocate four protons across biological membranes, thereby establishing the proton gradient required for ATP synthesis1. The full turnover of the CcO reaction involves an oxidative phase, in which the reduced enzyme (R) is oxidized by molecular oxygen to the metastable oxidized OH state, and a reductive phase, in which OH is reduced back to the R state. During each of the two phases, two protons are translocated across the membranes2. However, if OH is allowed to relax to the resting oxidized state (O), a redox equivalent to OH, its subsequent reduction to R is incapable of driving proton translocation2,3. How the O state structurally differs from OH remains an enigma in modern bioenergetics. Here, with resonance Raman spectroscopy and serial femtosecond X-ray crystallography (SFX)4, we show that the heme a3 iron and CuB in the active site of the O state, like those in the OH state5,6, are coordinated by a hydroxide ion and a water molecule, respectively. However, Y244, a residue covalently linked to one of the three CuB ligands and critical for the oxygen reduction chemistry, is in the neutral protonated form, which distinguishes O from OH, where Y244 is in the deprotonated tyrosinate form. These structural characteristics of O provide new insights into the proton translocation mechanism of CcO.


Mammalian CcO is a large integral membrane protein comprised of 13 subunits. It contains four redox active centers, CuA, heme a, and a heme a3/CuB binuclear center (BNC) (Fig. 1A). Molecular oxygen binds to the heme a3 iron in the BNC, where it is reduced to two water molecules by accepting four electrons from cytochrome c and four protons (the “substrate” protons) from the negative side (N-side) of the mitochondrial membrane (Fig. 1A). The energy derived from the oxygen reduction chemistry is used to drive the translocation of four protons (the “pumped” protons) from the N-side to the positive side (P-side) of the membrane1,7. Strong evidence suggests that the substrate protons are delivered to the BNC via the D and K-channel (see Extended Data Fig. 1), while the pumped protons are translocated via the D-channel810 or the H-channel11 through a putative proton loading site (PLS) located between the heme a3 propionates and a Mg2+ center1215.

Fig. 1. Oxygen reduction reaction catalyzed by bCcO.

Fig. 1.

(A) Schematic illustration of the four redox active metal centers in bCcO and the electron and proton transfers associated with the O2 reduction reaction. The entry of O2 and four substrate protons into the BNC, as well as the release of the product water molecules out of it, are indicated by the blue arrows. The associated entry of four electrons into the BNC and the translocation of four pumped protons across the membrane are indicated by the green and red arrows, respectively. The putative PLS between heme a3 and the Mg center is highlighted by the light blue background. (B) The overall O2 reduction reaction and the associated mechanism. The P intermediate is a general term for the PM and PR intermediates. The entry of the electrons and substrate protons into the BNC and the release of the product water molecules are indicated in each step of the reaction as described in the main text. The coupled proton translocation reactions are indicated by the white arrows. If the OH intermediate produced at the end of the oxidative phase is allowed to relax to the resting O state, its reduction to R does not support proton translocation.

The oxygen reduction reaction catalyzed by CcO has been well-characterized6,1619. As illustrated in Fig. 1B, the reaction is initiated by O2 binding to the reduced enzyme, R, to generate the primary O2-complex (A). Upon accepting 2 electrons and 2 substrate protons into the BNC, A is converted to the oxidized OH state, via the P and F intermediates. This oxidative phase of the reaction is followed by the reductive phase, where OH is reduced back to R via the EH intermediate, by accepting two additional electrons and 2 substrate protons into the BNC. During the reaction cycle, each time an electron and a substrate proton enter the BNC, a pumped proton is translocated across the mitochondrial membrane, as indicated by the white arrows. Intriguingly, if the metastable OH state is allowed to relax to the resting O state, its reduction to R, unlike the OHR transition, does not drive proton translocation2,3, despite the fact that O and OH are redox equivalents.

The structural properties of OH, distinguishing it from the O state, have been elusive. Time-resolved resonance Raman spectroscopic studies of bovine CcO (bCcO) revealed that the heme a3 iron in the BNC of the OH state is coordinated by a hydroxide ion5,6, as evidenced by its characteristic νFe-OH stretching mode at 450 cm−1. In contrast, a comparable νFe-OH band has never been identified in the O state. As such, it has been thought that the inability of the O state to drive proton translocation is at least a partial result of a unique BNC ligation state16,20,21. The crystal structure of OH has not been determined, while those of O have been reported for various homologues2224 of CcO. It is clear that, in the O state, strong electron density associated with exogeneous ligand(s) is present between heme a3 and CuB in the BNC; its assignment, however, is controversial. The BNC ligand was first assigned to a peroxide ion bridging the two metal centers22,25, but the best fitted O-O bond distance is much longer than that of a typical ferric peroxide species (~1.48Å). Furthermore, it is uncertain how the peroxide is formed and why it is stable under the equilibrium conditions. Consequently, alternative assignments have been considered. Based on theoretical perspectives, the BNC ligand has been proposed to be a dioxygen26 or a water molecule27. In contrast, based on structural studies, the ligand in bCcO (PDB ID: 7TIE)28 and R. sphaeroides CcO (PDB ID: 2GSM)23 has been assigned as a water and a hydroxide coordinated to the heme a3 and CuB, respectively; although the O-O distance between the two ligands (~1.9–2.0 Å) is too close for a typical H-bond.

Recently, it was recognized that macromolecular crystallographic structures obtained with intense synchrotron light sources at cryogenic temperatures often suffer from radiation damage problems, in particular for proteins containing redox sensitive metal centers2931. It has been shown that, in the O structure of bCcO acquired with a typical synchrotron light source, all the four redox active metal centers were reduced, although its polypeptide scaffold remained in a native-like conformation28,32. Accordingly, new approaches, such as SFX4, have been developed and employed to overcome the radiation damage problems. With SFX, the diffraction patterns of randomly oriented microcrystals suspended in a solution jet are collected sequentially with an X-ray free electron laser (XFEL) before they are destroyed by the intense femtosecond laser pulses. As such, radiation damage-free structures can be obtained at room temperature. Using SFX, Branden and coworkers obtained a radiation damage-free O structure of the ba3 oxidase from Thermus thermophilus, based on which it was concluded that the electron density in the BNC was best modeled by a ligand with a single oxygen atom, either a water or a hydroxide ion24. Likewise, we have used SFX to determine the radiation damage free O structure of bCcO33; however, we found that it required two oxygen atoms to account for the ligand electron density in the BNC, although the resolution (2.9 Å) was insufficient to clarify the identity of the ligands. On the other hand, Yoshikawa et al employed a different point-by-point scanning approach, using an XFEL as a light source, to circumvent radiation damage problems, based on which the BNC ligands of the O derivative of bCcO were assigned as two co-existing peroxide moieties34. Despite these and other efforts, no consensus on the ligand identity has been reached to date. Here, we sought to clarify the structural properties of the O derivatives of bCcO by using a combination of resonance Raman spectroscopy and SFX.

Identification of the heme a3 ligand by resonance Raman spectroscopy.

To determine the identity of the heme a3 iron ligand, we carried out resonance Raman spectroscopic studies in free soluton. The 413.1 nm output from a krypton ion laser was selected as the excitiation light source to selectively enhance the signals associated with heme a3. We reasoned that if the heme a3 iron ligand is a water or a hydroxide ion, it should be able to be exchanged with the solvent water molecules. Accordingly, we incubated the resting O derivative of bCcO in isotope-substituted H218O buffer for 12 hours to ensure complete solvent exchange prior to the resonance Raman measurements. To prevent photoreduction, the laser power was kept low (~5 mW) and the spectral acquisition time was kept short (3 mins); in addition, the spectra from 6 fresh samples were acquired and summed to improve the signal-to-noise ratio of the spectrum. As a comparison, the spectrum of O in naturally abundant H216O buffer was obtained in the same fashion.

As shown in Fig. 2, an oxygen isotope sensitive band was identified at 451 cm−1 in the H216O buffer, which shifted to 428 cm−1 in the H218O buffer. The isotopic shift of 23 cm−1 is consistent with the theoretical shift of a Fe-OH stretching mode (νFe-OH) (24 cm−1), indicating that the heme a3 iron ligand of the resting O state is a hydroxide ion. It should be noted that, this solvent isotope sensitive mode was not detected in prior studies6, possibly due to the complications resulting from laser induced photodamage35. The νFe-OH mode is identical to that found in the OH state5,6, suggesting that the BNC ligands in O and OH are the same, contrary to the common belief that they are distinct.16,20,21 It is noteworthy that this Fe-OH stretching frequency (451 cm−1) is remarkably low as compared to those of other ferric heme species (~490–550 cm1)36, indicating an unusually weak Fe-OH coordination bond. Hydroxide is generally a strong field ligand for ferric heme iron, which is associated with a strong Fe-OH bond and a low spin electronic configuration. However, previous resonance Raman6 and electron paramagnetic resonance (EPR)37 spectroscopic studies revealed that the heme a3 in the O state, like that in the OH state, has an unusual high spin configuration. We attribute the weak Fe-OH bond and unique high spin configuration of the heme a3 to a strong H-bond between the hydroxide ligand and its surrounding environment, as that detected in a hemoglobin from M. tuberculosis, which exhibits a similar low Fe-OH stretching frequency (454 cm−1) and a high spin electronic configuration due to a H-bond between the hydroxide ligand and a nearby tyrosine residue38. The presence of a strong H-bond to the hydroxide ligand in the BNC of bCcO is supported by the structural data discussed below.

Fig. 2. Resonance Raman spectrum of the O state of bCcO in H216O (black) versus H218O (red).

Fig. 2.

The H216O-H218O difference spectrum (expanded by 5 fold) is shown at the bottom. The oxygen sensitive mode in the H216O sample centered at 451 cm−1 that shifted to 428 cm−1 in the H218O sample is assigned to the νFe-OH mode.

Determination of the structure of the O state by SFX.

For the SFX measurements, microcrystals of bCcO were prepared in the resting O state using a previously reported protocol33. To ensure the homogeneity of the O state, the microcrystals were reduced under anaerobic conditions and then allowed to turn over by exposing to O2 and subsequently relax back to the O state by incubating overnight in a stabilizing solution. The suspension of the microcrystals was loaded into a gas-tight syringe and injected into the XFEL beam as a free solution jet with a single capillary MESH injector39,40. The XFEL beam, perpendicular to the solution jet, was directed into the tip of the Taylor cone formed at the output of the MESH injector. X-ray diffraction was collected for approximately 2 hours, from which 84,736 indexable diffraction patterns were selected for structural analysis. The structure was solved and refined to a resolution of 2.38 Å (Extended Data, Table 1). The structural markers for the oxidation states of the four redox centers confirm that the enzyme is in the fully oxidized O state (Extended Data Fig. 2).

Structural characterization of the BNC.

In the FO-FC electron density map associated with the SFX data (Fig. 3A), a large 2-lobe electron density is evident in the BNC, indicating the presence of ligands coordinated to heme a3 iron and CuB. As guided by the resonance Raman data (Fig. 2), we modeled the heme a3 ligand density with a OH ion (Fig. 3B). In addition, we modeled the CuB ligand density with a water molecule, as the coexistence of two negatively charged hydroxide ions in the BNC is expected to be energetically unfavorable. The occupancy of the ligands is confirmed by the polder maps shown in Fig. 3C. The Fe-OH, CuB-H2O and Fe-CuB bond lengths, which were unrestrained during the refinement, are determined to be 1.90, 2.14 and 4.74 Å, respectively. The O-O distance between the two oxygen ligands is 2.53Å, which is shorter than a typical H-bond, but is consistent with a strong low-barrier H-bond41,42. This strong H-bond between the two ligands plausibly weakens the ligand field strength of the hydroxide and destabilizes the Fe-OH bond, thereby accounting for the high spin electronic configuration and the low Fe-OH stretching frequency revealed by the spectroscopic studies. Taken together our data demonstrate for the first time that the heme a3 iron and CuB in the O state, like those in the OH state, are coordinated by a hydroxide ion and a water molecule, respectively.

Fig. 3. Electron density maps of the BNC in the O state of bCcO.

Fig. 3.

(A) The FO-FC electron density map (contoured at 7.0 σ) showing clear 2-lobe electron density associated with the BNC ligands. (B) The 2FO-FC electron density map (contoured at 2.5 σ) obtained with the electron density modeled with a hydroxide ion coordinated to the heme a3 iron and a water molecule coordinated to CuB. (C) The Polder map (contoured at 7.0 σ) associated with the BNC ligands.

Protonation state of Y244.

CuB in the BNC is coordinated by three histidine ligands, one of which (H240) forms a covalent bond with Y244 by a posttranslational modification (Fig. 4). It is well-established that, during the catalytic reaction, Y244 temporarily donates an electron and a proton to the heme a3 bound O2 to promote the O-O bond scission, by forming a tyrosyl radical43, and that its re-reduction to a tyrosinate and re-protonation back to its neutral protonated form are tightly coupled to the ensuing electron and proton transfer processes20,43,44.

Fig. 4. Protonation state of Y244 in the PR (A) and O (B) states.

Fig. 4.

The post translationally modified Y244 forms a H-bonding network with the OH group of the farnesyl side chain of heme a3, a water molecule (W1) and T316. In the PR state, an additional water, W2, is recruited into the BNC to stabilize the tyrosinate configuration of Y244. This water is absent in the O state reported here, as evident in the 2FO-FC electron density map (contoured at 1.0 σ) shown in the lower inset, signifying that Y244 is in the neutral protonated state. For clarity the BNC ligands are not shown. The oxygen atom and hydrogen atoms are shown as red and white spheres.

Previously, with time-resolved SFX, we showed that, in the PR intermediate, Y244 is in the tyrosinate form33. Next to the Y244, there is a water molecule within a H-bonding distance from the oxygen atom of the tyrosinate (indicated as W2 in Fig. 4A), which is not present in the reduced R state (PDB IDs: 6NMF and 7THU) or the CO complex (PDB ID: 5W97, a structural analog of the A state), where Y244 is in the neutral protonated form. It suggests that, in the PR state, W2 is recruited into the BNC to stabilize the tyrosinate configuration of Y244, similar to the water rearrangement induced by tyrosine deprotonation found in a photosynthetic reaction center from B. viridis45. Intriguingly, our current work reveals that W2 is not present in the O state (Fig. 4B), signifying that Y244 is in the neutral protonated form. Although the structures of the F and OH intermediates have not been determined, infrared spectroscopic studies demonstrate that Y244 in both F and OH, like that in the PR intermediate, is deprotonated44, indicating that during the PRFOH transition, Y244 remains in the tyrosinate configuration. This scenario is in good agreement with recent structural data showing the presence of W2 in the mixed oxygen intermediates of bCcO21,46. Our current data further demonstrate that the OHO transition is associated with the protonation of the tyrosinate (Y244).

The oxygen reaction cycle.

With the clarification of the O structure, we propose a complete reaction cycle of CcO as illustrated in Fig. 5. The reduced R state first binds O2 to form the primary oxy intermediate A, with a Fe3+-O2− electronic configuration47. By accepting an electron and a proton from Y244, the O-O bond in A is heterolytically cleaved, leading to the formation of the putative PM intermediate, where one oxygen remains on the heme a3 iron, in a ferryl (Fe4+=O2−) configuration, and the other oxygen is coordinated to CuB as a hydroxide, while Y244 is converted to a neutral tyrosyl radical. The entry of one electron into the BNC leads to the conversion of PM to PR, where the tyrosyl radical is reduced to a tyrosinate. The PMPR transition is associated with the entry of a new water (W2, not shown in Fig. 5 for clarity), which stabilizes the tyrosinate configuration of Y24433. The subsequent entry of a substrate proton into the BNC further transforms PR to F, where the hydroxide ligand of CuB is protonated to a water, which strengthens the iron-oxygen bond as evidenced by the shift of the frequency of the Fe4+=O2− stretching mode from 785 to 804 cm−1.48 Finally, the entry of an additional electron and a substrate proton into the BNC converts F to OH, where the Fe4+=O2− moiety is reduced to the Fe3+-OH species5,6,48. During this oxidative phase, one pumped proton is translocated during each of the PRF and FOH transitions (as indicated by the white arrows) and, throughout the PRFOH transformation, Y244 remains in the tyrosinate form.

Fig. 5. Hypothesized ligand transformation in the BNC during the CcO reaction cycle.

Fig. 5.

The oxidative and reductive phase of the reaction cycle are highlighted with green and blue backgrounds, respectively. The white arrows indicate the proton translocation reactions associated with the reaction cycle. The lifetimes associated with the PRF, FOH and OHO transitions are indicated in red.

In the ensuing reductive phase, an additional electron and a substrate proton enter the BNC, leading to the conversion of OH to EH, where CuB is reduced from the cupric to cuprous state and the hydroxide ligand of the heme a3 is protonated to a water. At the same time, the water ligand of CuB is released out of the BNC. The entry of another electron and a substrate proton into the BNC leads to the conversion of EH to R, where the heme a3 iron is reduced from the ferric to ferrous state and its water ligand is released out of the BNC; at the same time the tyrosinate is protonated back to its neutral form. During this reductive phase, one additional pumped proton is translocated during each of the OHEH and EHR transitions. Under electron deficient conditions, the OH intermediate produced at the end of the oxidative phase can spontaneously and slowly relax to the resting O state3. Our current data revealed that during the OHO transition, the tyrosinate (Y244) is protonated to the neutral form, leading to the dissociation of the W2 that stabilizes the tyrosinate, while the BNC ligands remain unchanged.

Implications on proton translocation.

It has been shown that the entry of the first two substrate protons into the BNC, associated with the PRF and FOH transitions, is mediated by the D-channel and occurs rapidly (within ~100 s and 1.5 ms, respectively) 1. Similarly, the entry of the other two substrate protons into the BNC, associated with the OHEH and EHR transitions, also takes place quickly (on the submillisecond time scale), although it is mediated by a different channel, the K-channel49. In sharp contrast, the off-pathway OHO transition is sluggish and does not reach completion until ~30 s,3 suggesting that the tyrosinate (Y244) is likely protonated by an adventitious proton from its surrounding environment, rather than a substrate proton from the K-channel.

Based on the electroneutrality principle proposed by Rich et al50,51, during the catalytic reaction, the entry of each electron into the BNC (see the green arrows in Fig. 6A) is charge-compensated by the entry of one substrate proton from the D or K-channel (blue arrows). The redox energy thereby derived is then used to drive the release of a pumped proton into the P-side of the membrane (red arrows) from the PLS, which is preloaded with the pumped proton(s) via the D or H-channel. As illustrated in Fig. 5, Y244 in all the intermediate states active in proton translocation (PR, F, OH, and EH) is in the deprotonated tyrosinate form, suggesting that the premature protonation of the tyrosinate (Y244) during the OHO transition, without the input of any electron into the BNC perturbs the charge balance in the BNC of the O state, thereby disabling its ability to release pumped protons out of the PLS upon its reduction (Fig. 6B). This scenario aligns well with recent computational studies demonstrating the importance of deprotonated forms of Y244 in modulating the energy landscape of the CcO reaction to promote the coupling of the oxygen reduction chemistry to proton translocation52.

Fig. 6. Functional role of Y244 during the CcO reaction cycle.

Fig. 6.

(A) During the active turnover, Y244 cycles between the neutral form (YH), tyrosyl radical form (Y) and deprotonated tyrosinate form (Y) as depicted by the blue cycle. In all the intermediate states active in proton translocation, Y244 is in the Y form (in red), which ensures the tight coupling of electron transfer (green arrows) and substrate proton transfer (blue arrows), via the D and K-channel into the BNC, to drive the proton translocation (red arrows) via the D or H channel from the N to P-side of the membrane. (B) The protonation of the tyrosinate to the YH form (red) in the O state disables the proton translocation upon its reduction to R.

Conclusions.

Previous studies reveal that O and OH are redox equivalents, but only the latter, not the former, is capable of translocating protons upon reduction. With a combination of resonance Raman spectroscopy and SFX, we now clarify that the heme a3 iron and CuB in the BNC of the O state, like those in the OH state, are coordinated by a hydroxide ion and water, respectively; in addition, we show that the post-translationally modified Y244 is in the neutral protonated form, which distinguishes the O state from the OH state, where Y244 is in the deprotonated tyrosinate form. Our data underscore the pivotal role of the deprotonated form of Y244, a residue fully conserved in the CcO family of enzymes, in energizing the enzyme for proton translocation, as supported by reported computational studies52.

Materials and Methods

Protein sample preparation.

Bovine CcO was isolated from bovine hearts by a standard procedure53,54. In the final step of the purification, the enzyme was crystallized by concentration on an Amicon concentrator equipped with a 200 kDa molecular cutoff filter. The crude crystals were harvested and redissolved in 40 mM pH 6.8 phosphate buffer containing 0.2% decylmaltoside to generate the protein stock for the resonance Raman measurements and microcrystal preparation for the SFX studies.

Resonance Raman measurements.

To prepare the sample in H218O, a concentrated bCcO sample (in 40 mM pH 7.4 phosphate buffer containing 0.2% decylmaltoside) was diluted by 10-fold with H218O containing the same buffer and then incubated overnight prior to the resonance Raman measurements. The final protein concentration was 30 μM. An equivalent sample in H216O was prepared in the same fashion as a comparison. Resonance Raman spectra were obtained by using 413.1 nm excitation from a Kr ion laser (Spectra Physics, Mountain View, CA). The laser beam was focused to a ~30 μm spot on the spinning quartz cell rotating at ~1000 rpm. The scattered light, collected at right angle to the incident laser beam, was focused on the 100 μm wide entrance slit of a 1.25 m Spex spectrometer equipped with a 1200 grooves/mm grating (Horiba Jobin Yvon, Edison, NJ), where it was dispersed and then detected by a liquid-nitrogen cooled CCD detector (Princeton Instruments, Trenton, NJ). A holographic notch filter (Kaiser, Ann Arbor, MI) was used to remove the laser scattering. The Raman shift was calibrated by using indene (Sigma).

It has been shown that high laser power can induce photoreduction linked artifacts in the resonance Raman spectra of bCcO35, which prevented identification of the Fe-OH stretching mode in a prior study6. As such, we kept the laser power low (~5 mW at the sample) and limited the laser exposure time to 3 minutes for each sample to avoid photoreduction and photodamage. A total of 6 spectra were acquired from fresh samples and averaged to improve the signal to noise ratio of the spectrum. To assure that artifacts were not present, spectra of the H216O and H218O buffers alone were obtained. It was confirmed that no isotopic differences in the 400 – 450 cm−1 window were detected.

Microcrystal preparation.

The microcrystals were prepared with a previously reported method33. The crystal growth was initiated by mixing the protein stock with the precipitant solution (0.2% decylmaltoside and 2.5% PEG4000 in 40 mM pH 6.8 phosphate buffer) and a seeding solution (prepared by crushing and sonicating large crystals in the mother solution). The microcrystals were allowed to grow at 4° C for ~36 hours before they were harvested and characterized by polarized optical microscopy. The microcrystals have a planar shape with approximate dimensions of ~20 × 20 × 4 μm. To obtain a homogeneous sample of the oxidized O crystals for the SFX measurements, the microcrystals were reduced anaerobically by a minimum amount of dithionite in a glove box and then thoroughly washed with the mother solution to remove excess dithionite and its oxidized products. The reduced microcrystals were then exposed to O2 to initiate the enzyme turnover. They were allowed to relax in a stabilizing solution (0.2 % decylmaltoside and 6.25% PEG-4000 in 40 mM pH 6.8 sodium phosphate solution) at 4 °C for ~24 hours prior to the SFX measurements.

SFX data acquisition and structural analysis.

The SFX measurements were conducted at the Macromolecular Femtosecond Crystallography (MFX) end station of the Linac Coherent Light Source (LCLS) at the SLAC National Accelerator Laboratory. A bCcO microcrystal slurry was loaded into a gas tight syringe and driven by a HPLC pump into a 100 μm diameter capillary of a Microfluidic Electrokinetic Sample Holder (MESH) injector,39,40 which has recently been developed as a useful and reliable technique for delivering microcrystal slurries into the XFEL beam5559. A high voltage (~+2500 V) was applied to the sample at the entrance of the capillary against a grounded waste collector. It was used to electro-focus the microcrystal jet down to a Taylor cone at the capillary output. The 10 keV / 30 fs pulses from the X-ray free electron laser (XFEL) intersected the microcrystal slurry at the tip of the Taylor cone prior to its development into a thin jet, as the jet was too unstable for data collection, while the thick region of the cone gave too many multiple hits and a high background. The diameter of the XFEL beam was ~3 μm. The sample flow rate was set to ~3 μl/min. A series of diffraction patterns from randomly orientated microcrystals were collected with a Rayonix MX340-XFEL CCD detector at a 30 Hz rep rate.

The quality and hit rate of the SFX data were monitored in real time using OM60. The data were collected for approximately 2 hours. Psocake61,62 was used to determine the initial diffraction geometry and find crystal hits. CrystFEL’s indexing program was used to index the crystal hits63,64. A total of 84,736 crystals were indexed. The initial structure was solved with molecular replacement with Phaser-MR through the CCP4 program suite65 using a 1.9 Å resolution structure of bCcO (PDB ID: 7TIE) as the search model. Waters and BNC ligands were excluded from the search model. Further model building was performed using Coot66. Structure refinements were done using Refmac5 and PDB-Redo67. The final structure was refined to a resolution of 2.38 Å (see Extended Data Table 1) (PDB ID: 8GCQ).

Supplementary Material

Supplement 1
media-1.pdf (340.3KB, pdf)

ACKNOWLEDGEMENTS.

The SFX experiments were carried out at the Linac Coherent Light Source (LCLS) at the SLAC National Accelerator Laboratory. LCLS is an Office of Science User Facility operated for the US Department of Energy Office of Science by Stanford University. Use of the LCLS, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science and Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The HERA system for in helium experiments at MFX was developed by Bruce Doak and funded by the Max-Planck Institute for Medical Research. This work was supported by National Science Foundation (NSF) CHE-1404929 (D.L.R. and S.-R.Y.) and National Institutes of Health (NIH) grants S10 OD023453, P41 GM139687, GM126297 (D.L.R. and S.-R.Y.) and GM115773 (S.-R.Y.).

References

  • 1.Wikstrom M., Krab K. & Sharma V. Oxygen Activation and Energy Conservation by Cytochrome c Oxidase. Chemical reviews 118, 2469–2490, doi: 10.1021/acs.chemrev.7b00664 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Verkhovsky M. I., Jasaitis A., Verkhovskaya M. L., Morgan J. E. & Wikstrom M. Proton translocation by cytochrome c oxidase. Nature 400, 480–483, doi: 10.1038/22813 (1999). [DOI] [PubMed] [Google Scholar]
  • 3.Bloch D. et al. The catalytic cycle of cytochrome c oxidase is not the sum of its two halves. Proceedings of the National Academy of Sciences of the United States of America 101, 529–533, doi: 10.1073/pnas.0306036101 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Boutet S. et al. High-resolution protein structure determination by serial femtosecond crystallography. Science 337, 362–364, doi: 10.1126/science.1217737 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Han S., Ching Y. C. & Rousseau D. L. Ferryl and hydroxy intermediates in the reaction of oxygen with reduced cytochrome c oxidase. Nature 348, 89–90, doi: 10.1038/348089a0 (1990). [DOI] [PubMed] [Google Scholar]
  • 6.Han S., Takahashi S. & Rousseau D. L. Time dependence of the catalytic intermediates in cytochrome c oxidase. The Journal of biological chemistry 275, 1910–1919 (2000). [DOI] [PubMed] [Google Scholar]
  • 7.Brzezinski P. Redox-driven membrane-bound proton pumps. Trends in biochemical sciences 29, 380–387 (2004). [DOI] [PubMed] [Google Scholar]
  • 8.Konstantinov A. A., Siletsky S., Mitchell D., Kaulen A. & Gennis R. B. The roles of the two proton input channels in cytochrome c oxidase from Rhodobacter sphaeroides probed by the effects of site-directed mutations on time-resolved electrogenic intraprotein proton transfer. Proceedings of the National Academy of Sciences of the United States of America 94, 9085–9090, doi: 10.1073/pnas.94.17.9085 (1997). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rich P. R. & Marechal A. Functions of the hydrophilic channels in protonmotive cytochrome c oxidase. J R Soc Interface 10, 20130183, doi: 10.1098/rsif.2013.0183 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wikstrom M., Jasaitis A., Backgren C., Puustinen A. & Verkhovsky M. I. The role of the D- and K-pathways of proton transfer in the function of the haem-copper oxidases. Biochimica et biophysica acta 1459, 514–520, doi: 10.1016/s0005-2728(00)00191-2 (2000). [DOI] [PubMed] [Google Scholar]
  • 11.Shimokata K. et al. The proton pumping pathway of bovine heart cytochrome c oxidase. Proceedings of the National Academy of Sciences of the United States of America 104, 4200–4205, doi: 10.1073/pnas.0611627104 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kaila V. R., Sharma V. & Wikstrom M. The identity of the transient proton loading site of the proton-pumping mechanism of cytochrome c oxidase. Biochimica et biophysica acta 1807, 80–84, doi: 10.1016/j.bbabio.2010.08.014 (2011). [DOI] [PubMed] [Google Scholar]
  • 13.Lu J. & Gunner M. R. Characterizing the proton loading site in cytochrome c oxidase. Proceedings of the National Academy of Sciences of the United States of America 111, 12414–12419, doi: 10.1073/pnas.1407187111 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sharpe M. A. & Ferguson-Miller S. A chemically explicit model for the mechanism of proton pumping in heme-copper oxidases. Journal of bioenergetics and biomembranes 40, 541–549, doi: 10.1007/s10863-008-9182-6 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Supekar S., Gamiz-Hernandez A. P. & Kaila V. R. A Protonated Water Cluster as a Transient Proton-Loading Site in Cytochrome c Oxidase. Angewandte Chemie 55, 11940–11944, doi: 10.1002/anie.201603606 (2016). [DOI] [PubMed] [Google Scholar]
  • 16.Belevich I. & Verkhovsky M. I. Molecular mechanism of proton translocation by cytochrome c oxidase. Antioxid Redox Signal 10, 1–29, doi: 10.1089/ars.2007.1705 (2008). [DOI] [PubMed] [Google Scholar]
  • 17.Kitagawa T. & Ogura T. Time-resolved resonance Raman investigation of oxygen reduction mechanism of bovine cytochrome c oxidase. Journal of bioenergetics and biomembranes 30, 71–79 (1998). [DOI] [PubMed] [Google Scholar]
  • 18.Wikstrom M., Gennis R. B. & Rich P. R. Structures of the intermediates in the catalytic cycle of mitochondrial cytochrome c oxidase. Biochimica et biophysica acta. Bioenergetics 1864, 148933, doi: 10.1016/j.bbabio.2022.148933 (2022). [DOI] [PubMed] [Google Scholar]
  • 19.Varotsis C., Zhang Y., Appelman E. H. & Babcock G. T. Resolution of the reaction sequence during the reduction of O2 by cytochrome oxidase. Proceedings of the National Academy of Sciences of the United States of America 90, 237–241, doi: 10.1073/pnas.90.1.237 (1993). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Sharma V., Karlin K. D. & Wikstrom M. Computational study of the activated O(H) state in the catalytic mechanism of cytochrome c oxidase. Proceedings of the National Academy of Sciences of the United States of America 110, 16844–16849, doi: 10.1073/pnas.1220379110 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Shimada A. et al. Critical roles of the CuB site in efficient proton pumping as revealed by crystal structures of mammalian cytochrome c oxidase catalytic intermediates. The Journal of biological chemistry 297, 100967, doi: 10.1016/j.jbc.2021.100967 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Koepke J. et al. High resolution crystal structure of Paracoccus denitrificans cytochrome c oxidase: new insights into the active site and the proton transfer pathways. Biochimica et biophysica acta 1787, 635–645, doi: 10.1016/j.bbabio.2009.04.003 (2009). [DOI] [PubMed] [Google Scholar]
  • 23.Qin L., Hiser C., Mulichak A., Garavito R. M. & Ferguson-Miller S. Identification of conserved lipid/detergent-binding sites in a high-resolution structure of the membrane protein cytochrome c oxidase. Proceedings of the National Academy of Sciences of the United States of America 103, 16117–16122, doi: 10.1073/pnas.0606149103 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Andersson R. et al. Serial femtosecond crystallography structure of cytochrome c oxidase at room temperature. Scientific reports 7, 4518, doi: 10.1038/s41598-017-04817-z (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Aoyama H. et al. A peroxide bridge between Fe and Cu ions in the O2 reduction site of fully oxidized cytochrome c oxidase could suppress the proton pump. Proceedings of the National Academy of Sciences of the United States of America 106, 2165–2169, doi: 10.1073/pnas.0806391106 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kaila V. R. et al. A combined quantum chemical and crystallographic study on the oxidized binuclear center of cytochrome c oxidase. Biochimica et biophysica acta 1807, 769–778, doi: 10.1016/j.bbabio.2010.12.016 (2011). [DOI] [PubMed] [Google Scholar]
  • 27.Noodleman L. et al. Coupled transport of electrons and protons in a bacterial cytochrome c oxidase-DFT calculated properties compared to structures and spectroscopies. Physical chemistry chemical physics : PCCP 22, 26652–26668, doi: 10.1039/d0cp04848h (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ishigami I., Russi S., Cohen A., Yeh S. R. & Rousseau D. L. Temperature-dependent structural transition following X-ray-induced metal center reduction in oxidized cytochrome c oxidase. The Journal of biological chemistry, 101799, doi: 10.1016/j.jbc.2022.101799 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Beitlich T., Kuhnel K., Schulze-Briese C., Shoeman R. L. & Schlichting I. Cryoradiolytic reduction of crystalline heme proteins: analysis by UV-Vis spectroscopy and X-ray crystallography. J Synchrotron Radiat 14, 11–23, doi: 10.1107/S0909049506049806 (2007). [DOI] [PubMed] [Google Scholar]
  • 30.Pfanzagl V. et al. X-ray-induced photoreduction of heme metal centers rapidly induces active-site perturbations in a protein-independent manner. The Journal of biological chemistry 295, 13488–13501, doi: 10.1074/jbc.RA120.014087 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Yi J., Orville A. M., Skinner J. M., Skinner M. J. & Richter-Addo G. B. Synchrotron X-ray-induced photoreduction of ferric myoglobin nitrite crystals gives the ferrous derivative with retention of the O-bonded nitrite ligand. Biochemistry 49, 5969–5971, doi: 10.1021/bi100801g (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Liu J., Qin L. & Ferguson-Miller S. Crystallographic and online spectral evidence for role of conformational change and conserved water in cytochrome oxidase proton pump. Proceedings of the National Academy of Sciences of the United States of America 108, 1284–1289, doi: 10.1073/pnas.1012846108 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Ishigami I. et al. Snapshot of an Oxygen Intermediate in the Catalytic Reaction of Cytochrome c Oxidase. Proc Nat Acad Sci (USA) 116, 3572–3577 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hirata K. et al. Determination of damage-free crystal structure of an X-ray-sensitive protein using an XFEL. Nature methods 11, 734–736, doi: 10.1038/nmeth.2962 (2014). [DOI] [PubMed] [Google Scholar]
  • 35.Han S. W., Ching Y. C. & Rousseau D. L. Evidence for a hydroxide intermediate in cytochrome c oxidase. The Journal of biological chemistry 264, 6604–6607 (1989). [PubMed] [Google Scholar]
  • 36.Feis A., Marzocchi M. P., Paoli M. & Smulevich G. Spin state and axial ligand bonding in the hydroxide complexes of metmyoglobin, methemoglobin, and horseradish peroxidase at room and low temperatures. Biochemistry 33, 4577–4583, doi: 10.1021/bi00181a019 (1994). [DOI] [PubMed] [Google Scholar]
  • 37.Brudvig G. W., Stevens T. H. & Chan S. I. Reactions of nitric oxide with cytochrome c oxidase. Biochemistry 19, 5275–5285, doi: 10.1021/bi00564a020 (1980). [DOI] [PubMed] [Google Scholar]
  • 38.Yeh S. R., Couture M., Ouellet Y., Guertin M. & Rousseau D. L. A cooperative oxygen binding hemoglobin from Mycobacterium tuberculosis. Stabilization of heme ligands by a distal tyrosine residue. The Journal of biological chemistry 275, 1679–1684, doi: 10.1074/jbc.275.3.1679 (2000). [DOI] [PubMed] [Google Scholar]
  • 39.Sierra R. G. et al. Concentric-flow electrokinetic injector enables serial crystallography of ribosome and photosystem II. Nature methods 13, 59–62, doi: 10.1038/nmeth.3667 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sierra R. G. et al. Nanoflow electrospinning serial femtosecond crystallography. Acta crystallographica. Section D, Biological crystallography 68, 1584–1587, doi: 10.1107/S0907444912038152 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Cleland W. W. in Advances in Physical Organic Chemistry Vol. 44 (ed Richard John P.) 1–17 (Academic Press, 2010). [Google Scholar]
  • 42.Hosur M. V. et al. Low-barrier hydrogen bonds in proteins. Crystallography Reviews 19, 3–50, doi: 10.1080/0889311X.2013.771633 (2013). [DOI] [Google Scholar]
  • 43.Gorbikova E. A., Belevich I., Wikstrom M. & Verkhovsky M. I. The proton donor for O-O bond scission by cytochrome c oxidase. Proceedings of the National Academy of Sciences of the United States of America 105, 10733–10737, doi: 10.1073/pnas.0802512105 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Gorbikova E. A., Wikstrom M. & Verkhovsky M. I. The protonation state of the cross-linked tyrosine during the catalytic cycle of cytochrome c oxidase. The Journal of biological chemistry 283, 34907–34912, doi: 10.1074/jbc.M803511200 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ishikita H. Tyrosine deprotonation and associated hydrogen bond rearrangements in a photosynthetic reaction center. PloS one 6, e26808, doi: 10.1371/journal.pone.0026808 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Shimada A. et al. X-ray structures of catalytic intermediates of cytochrome c oxidase provide insights into its O2 activation and unidirectional proton-pump mechanisms. The Journal of biological chemistry 295, 5818–5833, doi: 10.1074/jbc.RA119.009596 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Han S. W., Ching Y. C. & Rousseau D. L. Primary intermediate in the reaction of oxygen with fully reduced cytochrome c oxidase. Proceedings of the National Academy of Sciences of the United States of America 87, 2491–2495 (1990). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Ogura T. et al. Time-Resolved Resonance Raman Evidence for Tight Coupling between Electron Transfer and Proton Pumping of Cytochrome c Oxidase upon the Change from the FeV Oxidation Level to the FeIV Oxidation Level. Journal of the American Chemical Society 118, 5443–5449, doi: 10.1021/ja951922i (1996). [DOI] [Google Scholar]
  • 49.Ruitenberg M. et al. Single-electron reduction of the oxidized state is coupled to proton uptake via the K pathway in Paracoccus denitrificans cytochrome c oxidase. Proceedings of the National Academy of Sciences of the United States of America 97, 4632–4636, doi: 10.1073/pnas.080079097 (2000). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Mitchell R. & Rich P. R. Proton uptake by cytochrome c oxidase on reduction and on ligand binding. Biochimica et biophysica acta 1186, 19–26, doi: 10.1016/0005-2728(94)90130-9 (1994). [DOI] [PubMed] [Google Scholar]
  • 51.Rich P. R., Meunier B., Mitchell R. & John Moody A. Coupling of charge and proton movement in cytochrome c oxidase. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1275, 91–95, doi: 10.1016/0005-2728(96)00055-2 (1996). [DOI] [Google Scholar]
  • 52.Blomberg M. R. A. The Redox-Active Tyrosine Is Essential for Proton Pumping in Cytochrome c Oxidase. Frontiers in chemistry 9, 640155, doi: 10.3389/fchem.2021.640155 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Yoshikawa S., Choc M. G., O’Toole M. C. & Caughey W. S. An infrared study of CO binding to heart cytochrome c oxidase and hemoglobin A. Implications re O2 reactions. The Journal of biological chemistry 252, 5498–5508 (1977). [PubMed] [Google Scholar]
  • 54.Mochizuki M. et al. Quantitative reevaluation of the redox active sites of crystalline bovine heart cytochrome c oxidase. The Journal of biological chemistry 274, 33403–33411 (1999). [DOI] [PubMed] [Google Scholar]
  • 55.Ayan E. et al. Cooperative allostery and structural dynamics of streptavidin at cryogenic- and ambient-temperature. Communications biology 5, 73, doi: 10.1038/s42003-021-02903-7 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Ciftci H. et al. Structural insight into host plasma membrane association and assembly of HIV-1 matrix protein. Scientific reports 11, 15819, doi: 10.1038/s41598-021-95236-8 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Tetreau G. et al. Serial femtosecond crystallography on in vivo-grown crystals drives elucidation of mosquitocidal Cyt1Aa bioactivation cascade. Nature communications 11, 1153, doi: 10.1038/s41467-020-14894-w (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Wolff A. M. et al. Comparing serial X-ray crystallography and microcrystal electron diffraction (MicroED) as methods for routine structure determination from small macromolecular crystals. IUCrJ 7, 306–323, doi: 10.1107/S205225252000072X (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Colletier J. P. et al. De novo phasing with X-ray laser reveals mosquito larvicide BinAB structure. Nature 539, 43–47, doi: 10.1038/nature19825 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Mariani V. et al. OnDA: online data analysis and feedback for serial X-ray imaging. Journal of applied crystallography 49, 1073–1080, doi: 10.1107/S1600576716007469 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Damiani D. et al. Linac Coherent Light Source data analysis using psana. J. Appl. Cryst. 49, 672–679, doi:doi.org/ 10.1107/S1600576716004349 (2016). [DOI] [Google Scholar]
  • 62.Thayer J. et al. Data systems for the Linac coherent light source. Advanced structural and chemical imaging 3, 3, doi: 10.1186/s40679-016-0037-7 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.White T. A. et al. CrystFEL: a software suite for snapshot serial crystallography. Journal of applied crystallography 45, 335–341, doi: 10.1107/S0021889812002312 (2012). [DOI] [Google Scholar]
  • 64.White T. A. et al. Recent developments in CrystFEL. Journal of applied crystallography 49, 680–689, doi: 10.1107/S1600576716004751 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Computational C. The CCP4 suite: programs for protein crystallography. Acta crystallographica. Section D, Biological crystallography 50 Pt 5, 760–763 (1994). [DOI] [PubMed] [Google Scholar]
  • 66.Emsley P. & Cowtan K. Coot: model-building tools for molecular graphics. Acta crystallographica. Section D, Biological crystallography 60, 2126–2132, doi: 10.1107/S0907444904019158 (2004). [DOI] [PubMed] [Google Scholar]
  • 67.Joosten R. P., Long F., Murshudov G. N. & Perrakis A. The PDB_REDO server for macromolecular structure model optimization. IUCrJ 1, 213–220, doi: 10.1107/S2052252514009324 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement 1
media-1.pdf (340.3KB, pdf)

Articles from bioRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES